Trial Profile
Dose-ranging phase IIb clinical study of DP VPA in patients with epilepsy.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 16 Apr 2015
Price :
$35
*
At a glance
- Drugs DP-VPA (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- 16 Apr 2015 New trial record